Single-agent DTIC versus combination chemotherapy with or without immunotherapy in metastatic melanoma: a meta-analysis of 3273 patients from 20 randomized trials.
Melanoma Res. 2001 Feb;11(1):75-81. doi: 10.1097/00008390-200102000-00009.
Melanoma Res. 2001.
PMID: 11254118
Clinical Trial.